Medical/Pharmaceuticals
Nuevocor Doses First Patient in SUNBEAM-LMNA Phase 1/2 Trial and Receives FDA Fast Track Designation for NVC-001 in LMNA Dilated Cardiomyopathy
NVC-001 is designed to target the mechanobiological root cause of LMNA dilated cardiomyopathy and has disease-modifying potential SINGAPORE, PARIS and PHILADELPHIA, Oct. 8, 2026 /PRNewswire/ -- Nuevocor, a clinical-stage biotechnology company pioneering mechanobiology-targeted therapies designed...
2026-10-08 19:30
6385
LOTTE Biologics and Alvotech announce US-based manufacturing agreement to increase global supply
Collaboration covers multiple biosimilar products to be manufactured at LOTTE Biologics' Syracuse facility in New York Strategic long-term partnership with Alvotech to increase their global manufacturing capacity and support growth in demand SEOUL, South Korea and REYKJAVIK, Iceland, Oct. 8, 202...
2026-10-08 19:17
2549
Sisram Medical Announces Share Repurchase Plan for Up to 1% of Issued Shares
Reinforcing Confidence in Long-Term Growth and Commitment to Shareholder Returns HONG KONG, Oct. 8, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK), a global wellness group offering Energy-Based Devices ("EBD"), injectables, and other complementary solutions, today an...
2026-10-08 18:16
6272
Löviselle LEAP Advances Across Singapore and Malaysia: Building a Regional Platform for Bio-Active Regeneration
KUALA LUMPUR, Malaysia, Oct. 8, 2026 /PRNewswire/ -- Following the inaugural LEAP at a leading Singapore Medical Academy, Löviselle convened the first Malaysian LEAP at the Medical Academy of Malaysia. Over two days, more than 60 local physicians gathered around the theme "Beyond Stimulation, Tru...
2026-10-08 16:39
4009
Ribo Submits European Clinical Trial Application for Phase Ⅰ Study of INHBE-Targeting siRNA RBD3133
SUZHOU, China and MÖLNDAL, Sweden, Oct. 8, 2026 /PRNewswire/ -- Suzhou Ribo Life Science (06938.HK) and its subsidiary Ribocure Pharmaceuticals AB (collectively referred to as "Ribo") announced the successful submission of a Phase Ⅰ Clinical Trial Application (CTA) in EU for RBD3133, a novel siRN...
2026-10-08 09:47
2516
NCCN Highlights Collaborations to Improve Global Cancer Outcomes During Meetings in North America and Asia
National Comprehensive Cancer Network participates in annual conferences for the International Gynecologic Cancer Society and Philippine Society of Medical Oncology in efforts to standardize cancer treatment recommendations. MONTREAL and MANILA, Philippines, Oct. 8, 2026 /PRNewswire/ -- The Natio...
2026-10-08 09:06
5748
WuXi AppTec Earns EcoVadis Gold Medal for Third Consecutive Year, Ranking Among Global Top 5% for Sustainability
SHANGHAI, Oct. 7, 2026 /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), has received a Gold medal from EcoVadis for the third consecutive year, reflecting the Company's consistent commitment to sustainability. E...
2026-10-08 08:00
3655
Asieris Pharmaceuticals Enters an Exclusive Licensing Agreement with Theramex for CEVIRA® subject to certain conditions, Advancing the Global Development and Commercialization of a Non-Surgical Treatment for Cervical Precancerous Lesions in Europe
* Agreement is expected to grant Theramex exclusive rights to CEVIRA® in Europe, Australia, New Zealand and Turkey, while Asieris retains rights for the rest of the world. * The deal includes 15 million US dollars of upfront payment and a total of 11 million dollars of near-term regulatory mi...
2026-10-07 21:35
3113
Flat Medical Surpasses 30 U.S. Hospitals and Pain Centers Using the EpiFaith® Smart Syringe in Routine Clinical Practice
Adoption spans obstetric anesthesia and interventional pain management, as major integrated delivery networks begin groundwork for system-wide conversion AUSTIN, Texas, Oct. 7, 2026 /PRNewswire/ -- Flat Medical, a provider of precision needle access and guidance solutions for anesthesia, critical...
2026-10-07 20:08
3445
LG CNS Showcases Pharma-Specific Manufacturing AX at World's Largest Pharma-Biotech Show
* Participates in CPHI Milan 2026, Expanding Manufacturing AX Reach in Pharma * Showcasing key solutions for factory design, production operations, and quality management using the theme "Autonomous Factory in Pharma" SEOUL, South Korea and MILAN, Oct. 7, 2026 /PRNewswire/ -- LG CNS, a leading...
2026-10-07 20:00
2408
OncoBayes progressing OB-001 to tackle ADC resistance and TKI brain penetration
LONDON, Oct. 7, 2026 /PRNewswire/ -- OncoBayes, a privately held clinical-stage pharmaceutical company, today announced the successful completion of preclinical work with OB-001, demonstrating the product's potential to tackle two major unmet needs in oncology: ADC resistance and the brain pen...
2026-10-07 14:00
2634
Cambridge Heartwear Awarded £184 Million NHS Tender for World's First Medical-Grade, Wirelessly Charged, Reusable ECG Wearable
CAMBRIDGE, England, Oct. 7, 2026 /PRNewswire/ -- Cambridge Heartwear® Limited (
www.camheartwear.com
2026-10-07 01:13
4526
Cambridge Heartwear Awarded £184 Million NHS Tender for World's First Medical-Grade, Wirelessly Charged, Reusable ECG Wearable
CAMBRIDGE, England, Oct. 6, 2026 /PRNewswire/ -- Cambridge Heartwear® Limited (
www.camheartwear.com
2026-10-07 01:00
4751
XtalPi Debuts Kodexia™, the World's First Closed-Loop siRNA Platform Combining Generative AI with First-Principles Modeling
* This unified platform integrates sequence design, chemical modification, experimental validation, extrahepatic delivery design, and intellectual property strategy into an integrated computational–experimental workflow, pioneering in vivo efficacy prediction models to accelerate drug developme...
2026-10-06 22:42
5542
Hisun Pharmaceutical Celebrates 70th Anniversary with Global Partners at Milan-Taizhou Night
MILAN, Oct. 6, 2026 /PRNewswire/ -- Zhejiang Hisun Pharmaceutical Co., Ltd. hosted its 70th Anniversary Global Partners Appreciation Dinner in Milan on October 5, the eve of CPHI Milan 2026. Themed "Bridging Cultures, Advancing Health Together," the event brought together leading pharmaceutical c...
2026-10-06 21:32
2301
ZEISS demonstrates new digital and visual enhancements across ophthalmic workflows at AAO
ZEISS Medical Technology will showcase its latest innovations and digital technologies at AAO, including: * Connected cataract workflow –ZEISS VERACITY Surgery Planner reaches 3 million surgical cases planned through cloud-based software, supporting surgical efficiency built on automation and ...
2026-10-06 21:00
2447
Werfen Launches QUANTA Link® 5.0: A Modern, Web-Based Platform for Autoimmune Laboratory Workflow Management
A flexible, browser-based solution, QUANTA Link 5.0 centralizes autoimmune testing workflows. It enhances usability, streamlines workflows, and supports confident decision-making in today's autoimmune laboratories. SAN DIEGO, Oct. 6, 2026 /PRNewswire/ -- Werfen today announced the global launch ...
2026-10-06 20:00
3225
/C O R R E C T I O N -- Piramal Pharma Solutions/
In the news release, Piramal Pharma Solutions Launches New Microbiology Laboratory at Its Lexington, KY Sterile Injectable Facility, issued 06-Oct-2026 by Piramal Pharma Solutions over PR Newswire, we are advised by the company that changes have been made to the caption accompanying the first ima...
2026-10-06 16:59
3458
Lundbeck presents Phase Ib data for Lu AF28996 in advanced Parkinson's disease, as Phase II trial begins
* Results from an 18-week, open-label Phase Ib trial of investigational Lu AF28996 in people with advanced Parkinson's disease are being presented at MDS 2026 * The trial provided initial safety and tolerability data for Lu AF28996, with most treatment-emergent adverse events reported as mild...
2026-10-06 14:35
3424
Dr. Oregonin Completes U.S. FDA Registration for OLTIS DENTAL-X, Unveiling Oral-Care Innovation Rooted in Trans-Pacific Alder Research
Botanical oral-care product bridges 1974 Oregon State University discovery of 'oregonin' with 27 years of natural-product research by South Korean scientists. SEOUL, South Korea, Oct. 6, 2026 /PRNewswire/ -- Dr. Oregonin Inc. today announced that it has completed U.S. Food and Drug Administration...
2026-10-06 13:50
2690
Week's Top Stories
Most Reposted
Cyient, 3-GIS Partner to Help Telecom and Utility Operators Turn Network Data into Operational Control
[Picked up by 1154 media titles]
2026-11-11 22:00Royal Bank of Canada announces agreement to acquire Yarra Capital Management
[Picked up by 1143 media titles]
2026-11-09 21:00Algolia Powers Orange with AI Agents for Billing Support: NYSE Content Update
[Picked up by 1121 media titles]
2026-11-06 22:06
Cision Report Reveals the Consumer Trends Hidden Between Search, Social, and AI
[Picked up by 1109 media titles]
2026-11-09 23:00
Poppi Founders Launch Hydration Brand jetty: NYSE Content Update
[Picked up by 1083 media titles]
2026-11-10 22:17
Most Read
Home Companion Robot Mobo to Debut Globally and Open Pre-orders as AiMOGA Showcases Its Robot Family at the 2026 OMODA & JAECOO International User Summit
2026-11-07 13:49
26968
ZD Energy Unveils Overseas Smart Energy Solutions in Thailand, Leveraging Local Manufacturing and Scenario-Based Capabilities to Support the Country's Energy Transition
2026-11-06 22:12
15893
SILVERSEA MARKS HISTORIC OPENING OF THE CORMORANT AT 55 SOUTH, THE SOUTHERNMOST HOTEL ON EARTH, OFFERING A NEW GATEWAY TO ANTARCTICA
2026-11-07 01:05
15334
Algolia Powers Orange with AI Agents for Billing Support: NYSE Content Update
2026-11-06 22:06
12475